CLOV vs CUE
Clover Health Investments Corp (CLOV) versus Cue Biopharma (CUE) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
CLOV currently screens at market cap $1.55B. CUE currently screens at market cap $59.5M.
Not investment advice. Open the CLOV and CUE stock pages for the full models.
Not investment advice.